Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Popular weight-loss drugs like Ozempic, Wegovy and Zepbound produce significantly less weight loss in real-world settings ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic ...

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Oh-oh-oh Ozempic, you know it's not the only weight loss injectable that's got people talking these days. Roughly three years ago we were still figuring out why exactly a large chunk of the Real ...

NASHVILLE, Tenn. (WTVF) — We've all heard about Ozempic — a medication that treats diabetes but is largely used to lose weight. The drug has soared in popularity in the last few years.

So researchers have been wondering: Might blockbuster weight-loss drugs like Wegovy, Ozempic and Zepbound also play ... data from 43 U.S. health systems to compare two groups: people with obesity ...